10-Q Filing

AIM IMMUNOTECH INC. CIK: 946644 Q2 2017

Filing Information

Form Type	10-Q
Accession Number	`0001493152-17-009293`
Period End Date	20170630
Filing Date	20170814
Fiscal Year	2017
Fiscal Period	Q2
XBRL Instance	heb-20170630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 64 Income Statement 72 Cash Flow Statement 66 Stockholders Equity 13

Balance Sheet 64 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.12M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.22M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	-	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.41M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.54M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	-	shares	Point-in-time
Marketable securities	`AvailableForSaleSecuritiesCurrent`	$3.46M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	-	shares	Point-in-time
Marketable securities	`AvailableForSaleSecuritiesCurrent`	$1.99M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	-	shares	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$98.00K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	-	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Assets held for sale	`AssetsHeldForSaleNotPartOfDisposalGroupCurrent`	$764.00K	USD	Point-in-time
Assets held for sale	`AssetsHeldForSaleNotPartOfDisposalGroupCurrent`	$764.00K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	350.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	350.00M	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$607.00K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$309.00K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	24.20M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	28.96M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	28.96M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	24.20M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$4.68M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$6.94M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$9.02M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$9.51M	USD	Point-in-time
Patent and trademark rights, net	`FiniteLivedIntangibleAssetsNet`	$860.00K	USD	Point-in-time
Patent and trademark rights, net	`FiniteLivedIntangibleAssetsNet`	$872.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$1.55M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$1.55M	USD	Point-in-time
Total assets	`Assets`	$18.87M	USD	Point-in-time
Total assets	`Assets`	$16.11M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$887.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$972.00K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$1.77M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$1.55M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.44M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.74M	USD	Point-in-time
Note payable	`LongTermNotesPayable`	-	USD	Point-in-time
Note payable	`LongTermNotesPayable`	$517.00K	USD	Point-in-time
Redeemable warrants	`RedeemableWarrants`	$940.00K	USD	Point-in-time
Redeemable warrants	`RedeemableWarrants`	$2.52M	USD	Point-in-time
Commitments and contingencies (Note 6)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 6)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, par value $0.01 per share, authorized 5,000,000; issued and outstanding; none	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, par value $0.01 per share, authorized 5,000,000; issued and outstanding; none	`PreferredStockValue`	-	USD	Point-in-time
Common stock, par value $0.001 per share, authorized 350,000,000 shares; issued and outstanding 28,957,668 and 24,202,921, respectively	`CommonStockValue`	$24.00K	USD	Point-in-time
Common stock, par value $0.001 per share, authorized 350,000,000 shares; issued and outstanding 28,957,668 and 24,202,921, respectively	`CommonStockValue`	$29.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$316.31M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$315.98M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-5.00K	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$18.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-306.02M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-300.50M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$15.50M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$10.33M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$16.11M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$18.87M	USD	Point-in-time

Income Statement 72 line items

Line Item	Tag	Value	Unit	Period
Total revenues	`SalesRevenueNet`	$54.00K	USD	2 Qtrs
Total revenues	`SalesRevenueNet`	$213.00K	USD	1 Quarter
Total revenues	`SalesRevenueNet`	$297.00K	USD	2 Qtrs
Total revenues	`SalesRevenueNet`	$15.00K	USD	1 Quarter
Production costs	`ManufacturingCosts`	$488.00K	USD	2 Qtrs
Production costs	`ManufacturingCosts`	$290.00K	USD	1 Quarter
Production costs	`ManufacturingCosts`	$218.00K	USD	1 Quarter
Production costs	`ManufacturingCosts`	$558.00K	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$1.90M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$1.11M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$900.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$2.50M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$4.09M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$1.62M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$1.64M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$3.28M	USD	2 Qtrs
Total costs and expenses	`CostsAndExpenses`	$2.83M	USD	1 Quarter
Total costs and expenses	`CostsAndExpenses`	$6.55M	USD	2 Qtrs
Total costs and expenses	`CostsAndExpenses`	$6.27M	USD	2 Qtrs
Total costs and expenses	`CostsAndExpenses`	$2.94M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-2.73M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-6.49M	USD	2 Qtrs
Operating loss	`OperatingIncomeLoss`	$-5.97M	USD	2 Qtrs
Operating loss	`OperatingIncomeLoss`	$-2.81M	USD	1 Quarter
Interest expense and other finance costs	`InterestAndDebtExpense`	-	USD	1 Quarter
Interest expense and other finance costs	`InterestAndDebtExpense`	$19.00K	USD	2 Qtrs
Interest expense and other finance costs	`InterestAndDebtExpense`	$19.00K	USD	1 Quarter
Interest expense and other finance costs	`InterestAndDebtExpense`	-	USD	2 Qtrs
Interest and other income/expense	`InterestAndOtherIncome`	$116.00K	USD	2 Qtrs
Interest and other income/expense	`InterestAndOtherIncome`	$21.00K	USD	1 Quarter
Interest and other income/expense	`InterestAndOtherIncome`	$55.00K	USD	1 Quarter
Interest and other income/expense	`InterestAndOtherIncome`	$47.00K	USD	2 Qtrs
Redeemable warrants valuation adjustment	`FairValueAdjustmentOfWarrants`	-	USD	1 Quarter
Redeemable warrants valuation adjustment	`FairValueAdjustmentOfWarrants`	-	USD	2 Qtrs
Redeemable warrants valuation adjustment	`FairValueAdjustmentOfWarrants`	$-529.00K	USD	1 Quarter
Redeemable warrants valuation adjustment	`FairValueAdjustmentOfWarrants`	$-923.00K	USD	2 Qtrs
Insurance proceeds from legal settlement, net	`LitigationSettlementExpense`	-	USD	1 Quarter
Insurance proceeds from legal settlement, net	`LitigationSettlementExpense`	-	USD	2 Qtrs
Insurance proceeds from legal settlement, net	`LitigationSettlementExpense`	$-1.44M	USD	1 Quarter
Insurance proceeds from legal settlement, net	`LitigationSettlementExpense`	$-1.44M	USD	2 Qtrs
Gain (Loss) on sales of short term marketable securities	`MarketableSecuritiesGainLoss`	$-87.00K	USD	2 Qtrs
Gain (Loss) on sales of short term marketable securities	`MarketableSecuritiesGainLoss`	$6.00K	USD	1 Quarter
Gain (Loss) on sales of short term marketable securities	`MarketableSecuritiesGainLoss`	$20.00K	USD	1 Quarter
Gain (Loss) on sales of short term marketable securities	`MarketableSecuritiesGainLoss`	$6.00K	USD	2 Qtrs
Gain from sale of income tax net operating losses and research credits	`GainFromSaleOfIncomeTaxNetOperatingLossesAndResearchCredits`	$1.56M	USD	2 Qtrs
Gain from sale of income tax net operating losses and research credits	`GainFromSaleOfIncomeTaxNetOperatingLossesAndResearchCredits`	-	USD	1 Quarter
Gain from sale of income tax net operating losses and research credits	`GainFromSaleOfIncomeTaxNetOperatingLossesAndResearchCredits`	-	USD	1 Quarter
Gain from sale of income tax net operating losses and research credits	`GainFromSaleOfIncomeTaxNetOperatingLossesAndResearchCredits`	-	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-1.30M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-3.47M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-2.19M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-5.01M	USD	2 Qtrs
Reclassification adjustments for loss on sales of short term marketable securities included in net loss	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	-	USD	1 Quarter
Reclassification adjustments for loss on sales of short term marketable securities included in net loss	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-6.00K	USD	1 Quarter
Reclassification adjustments for loss on sales of short term marketable securities included in net loss	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-6.00K	USD	2 Qtrs
Reclassification adjustments for loss on sales of short term marketable securities included in net loss	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$87.00K	USD	2 Qtrs
Unrealized gain on marketable securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$29.00K	USD	2 Qtrs
Unrealized gain on marketable securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$18.00K	USD	1 Quarter
Unrealized gain on marketable securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$97.00K	USD	2 Qtrs
Unrealized gain on marketable securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$38.00K	USD	1 Quarter
Net comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-3.28M	USD	2 Qtrs
Net comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-4.92M	USD	2 Qtrs
Net comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-1.26M	USD	1 Quarter
Net comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-2.18M	USD	1 Quarter
Basic and diluted loss per share	`EarningsPerShareBasicAndDiluted`	$-0.16	USD	2 Qtrs
Basic and diluted loss per share	`EarningsPerShareBasicAndDiluted`	$-0.06	USD	1 Quarter
Basic and diluted loss per share	`EarningsPerShareBasicAndDiluted`	$-0.08	USD	1 Quarter
Basic and diluted loss per share	`EarningsPerShareBasicAndDiluted`	$-0.19	USD	2 Qtrs
Weighted average shares outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	27.31M	shares	1 Quarter
Weighted average shares outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	20.65M	shares	2 Qtrs
Weighted average shares outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	20.67M	shares	1 Quarter
Weighted average shares outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	26.33M	shares	2 Qtrs

Cash Flow Statement 66 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-1.30M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-3.47M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-2.19M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-5.01M	USD	2 Qtrs
Depreciation of property and equipment	`Depreciation`	$504.00K	USD	2 Qtrs
Depreciation of property and equipment	`Depreciation`	$576.00K	USD	2 Qtrs
Redeemable warrants valuation adjustment	`FairValueAdjustmentOfWarrants`	-	USD	1 Quarter
Redeemable warrants valuation adjustment	`FairValueAdjustmentOfWarrants`	-	USD	2 Qtrs
Redeemable warrants valuation adjustment	`FairValueAdjustmentOfWarrants`	$-529.00K	USD	1 Quarter
Redeemable warrants valuation adjustment	`FairValueAdjustmentOfWarrants`	$-923.00K	USD	2 Qtrs
Amortization and abandonment of patent and trademark rights	`AmortizationAndAbandonmentOfIntagibleAssets`	$70.00K	USD	2 Qtrs
Amortization and abandonment of patent and trademark rights	`AmortizationAndAbandonmentOfIntagibleAssets`	$17.00K	USD	2 Qtrs
Equity-based compensation	`StockOptionPlanExpense`	$238.00K	USD	2 Qtrs
Equity-based compensation	`StockOptionPlanExpense`	$101.00K	USD	2 Qtrs
Realized gain(loss) on sale of marketable securities	`MarketableSecuritiesRealizedGainLoss`	$-87.00K	USD	2 Qtrs
Realized gain(loss) on sale of marketable securities	`MarketableSecuritiesRealizedGainLoss`	$6.00K	USD	2 Qtrs
Escrow account for litigation settlement	`EscrowAccountForLitigationSettlement`	$-1.75M	USD	2 Qtrs
Escrow account for litigation settlement	`EscrowAccountForLitigationSettlement`	-	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	-	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$98.00K	USD	2 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$298.00K	USD	2 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$43.00K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$85.00K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$178.00K	USD	2 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$331.00K	USD	2 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$1.82M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$5.30M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-2.29M	USD	2 Qtrs
Sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$1.92M	USD	2 Qtrs
Sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$1.50M	USD	2 Qtrs
Purchase of property, equipment and construction in progress	`PaymentsToAcquirePropertyPlantAndEquipment`	$3.00K	USD	2 Qtrs
Purchase of property, equipment and construction in progress	`PaymentsToAcquirePropertyPlantAndEquipment`	$160.00K	USD	2 Qtrs
Lease deposit refund	`LeaseDepositRefund`	$2.00K	USD	2 Qtrs
Lease deposit refund	`LeaseDepositRefund`	-	USD	2 Qtrs
Additions to patent and trademark rights	`PaymentsToAcquireIntangibleAssets`	$14.00K	USD	2 Qtrs
Additions to patent and trademark rights	`PaymentsToAcquireIntangibleAssets`	$207.00K	USD	2 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$1.55M	USD	2 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$1.48M	USD	2 Qtrs
Payments on capital leases	`PaymentsOnCapitalLeases`	-	USD	2 Qtrs
Payments on capital leases	`PaymentsOnCapitalLeases`	$1.00K	USD	2 Qtrs
Debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$89.00K	USD	2 Qtrs
Debt issuance costs	`PaymentsOfDebtIssuanceCosts`	-	USD	2 Qtrs
Proceeds from note payable	`ProceedsFromNotesPayable`	$606.00K	USD	2 Qtrs
Proceeds from note payable	`ProceedsFromNotesPayable`	-	USD	2 Qtrs
Proceeds from sale of stock, net of issuance costs	`ProceedsFromIssuanceOfCommonStock`	$2.12M	USD	2 Qtrs
Proceeds from sale of stock, net of issuance costs	`ProceedsFromIssuanceOfCommonStock`	$163.00K	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$2.63M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$162.00K	USD	2 Qtrs
Net decrease in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-577.00K	USD	2 Qtrs
Net decrease in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-1.19M	USD	2 Qtrs
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$2.12M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$1.22M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$2.41M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$1.54M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$2.12M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$1.22M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$2.41M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$1.54M	USD	Point-in-time
Unrealized gain on marketable securities	`UnrealizedGainLossOnSecurities`	$29.00K	USD	2 Qtrs
Unrealized gain on marketable securities	`UnrealizedGainLossOnSecurities`	$184.00K	USD	2 Qtrs
Insurance proceeds from legal settlement	`InsuranceProceedsFromLegalSettlement`	-	USD	2 Qtrs
Insurance proceeds from legal settlement	`InsuranceProceedsFromLegalSettlement`	$3.54M	USD	2 Qtrs
Stock issued for accrued expenses	`StockIssued1`	-	USD	2 Qtrs
Stock issued for accrued expenses	`StockIssued1`	$106.00K	USD	2 Qtrs
Fair value of redeemable warrants granted	`FairValueOfRedeemableWarrants`	-	USD	2 Qtrs
Fair value of redeemable warrants granted	`FairValueOfRedeemableWarrants`	$1.99M	USD	2 Qtrs

Stockholders Equity 13 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquity`	$15.50M	USD	Point-in-time
Balance	`StockholdersEquity`	$10.33M	USD	Point-in-time
Equity-based compensation	`StockGrantedDuringPeriodValueSharebasedCompensation`	$101.00K	USD	2 Qtrs
Redeemable warrants	`AdjustmentsToAdditionalPaidInCapitalWarrantIssued`	$-1.99M	USD	2 Qtrs
Deemed dividends	`Dividends`	$-507.00K	USD	2 Qtrs
Common stock issuance, net of costs	`StockIssuedDuringPeriodValueNewIssues`	$2.12M	USD	2 Qtrs
Stock issued for accounts payable	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$106.00K	USD	2 Qtrs
Net comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$-3.28M	USD	2 Qtrs
Net comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$-4.92M	USD	2 Qtrs
Net comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$-1.26M	USD	1 Quarter
Net comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$-2.18M	USD	1 Quarter
Balance	`StockholdersEquity`	$15.50M	USD	Point-in-time
Balance	`StockholdersEquity`	$10.33M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.